Patent details

Basic Information

Publication number:

EP3160463

PCT Application Number:

IB2015054792

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157339268

PCT Publication Number:

WO2015198266

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INTERMITTENT DOSING OF MDM2 INHIBITOR

French Title of Invention:

ADMINISTRATION INTERMITTENTE D'INHIBITEUR DE MDM2

German Title of Invention:

INTERMITTIERENDE DOSIERUNG EINES MDM2-INHIBITORS

SPC Number:

Dates

Filing date:

25/06/2015

Grant date:

21/10/2020

EP Publication Date:

03/05/2017

PCT Publication Date:

30/12/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/10/2020

EP B1 Publication Date:

21/10/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/06/2021

Expiration date:

25/06/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/10/2020

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

JEAY, Sebastien

Address:

Switzerland (CH)

2

Name:

FERRETTI, Stephane

Address:

Switzerland (CH)

Priority

Priority Number:

201462017406 P

Priority Date:

26/06/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/402; A61K 31/404; A61K 31/4178; A61K 31/4418; A61K 31/4439; A61K 31/47; A61K 31/472; A61K 31/496; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202043

Publication date:

21/10/2020

Description:

Grant (B1)

2

Issue number:

202350

Publication date:

13/12/2023

Description:

Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages